Cargando…
A257 PANCREATIC CANCER TREATMENT AND END OF LIFE OUTCOMES: A POPULATION BASED COHORT STUDY
BACKGROUND: Patients with pancreatic cancer face challenging decisions regarding treatment choices following their diagnosis and often lack data on end-of-life (EOL) outcomes. Without the available information, older patients may be undertreated, dying earlier than they would have with treatment, wh...
Autores principales: | Khan, R, Salim, M, Tanuseputro, P, Hsu, A, Coburn, N, Talarico, R, James, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859383/ http://dx.doi.org/10.1093/jcag/gwab049.256 |
Ejemplares similares
-
A56 DEVELOPMENT OF A PROGNOSTIC SURVIVAL MODEL FOR PATIENTS DIAGNOSED WITH PANCREATIC CANCER IN ONTARIO
por: James, P, et al.
Publicado: (2023) -
Initial treatment is associated with improved survival and end-of-life outcomes for patients with pancreatic cancer: a cohort study
por: Khan, Rishad, et al.
Publicado: (2022) -
A225 VACCINE-PREVENTABLE DISEASES IN HOSPITALIZED PATIENTS WITH END-STAGE LIVER DISEASE/CIRRHOSIS: A NATIONWIDE COHORT ANALYSIS
por: Hudson, D, et al.
Publicado: (2022) -
A205 IS REPEAT ERCP REQUIRED AFTER INITIAL ENDOSCOPIC MANAGEMENT OF POST-SURGICAL BILE LEAKS? MULTI-CENTER VALIDATION OF THE CALGARY BILE LEAK RULE
por: Xiao, Y, et al.
Publicado: (2022) -
A215 CAUSE-SPECIFIC MORTALITY IN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED COHORT STUDY
por: Wang, P, et al.
Publicado: (2022)